Literature DB >> 5550353

Intradermal influenza immunization. Experience with Hong Kong vaccine.

M I Marks, J J Eller.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 5550353     DOI： 10.1164/arrd.1971.103.4.579

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  7 in total

1.  Efficacy of Influenza Inoculation: Intradermal versus Subcutaneous Route.

Authors:  D Lawee; D Steele; M Gutman; F Demanuele
Journal:  Can Fam Physician       Date:  1981-03       Impact factor: 3.275

2.  Letter: Influenza immunization in children.

Authors:  S Schevill; M I Marks
Journal:  Can Med Assoc J       Date:  1976-09-18       Impact factor: 8.262

Review 3.  Immunogenicity, safety and tolerability of intradermal influenza vaccines.

Authors:  Ivan F N Hung; Kwok-Yung Yuen
Journal:  Hum Vaccin Immunother       Date:  2017-07-06       Impact factor: 3.452

Review 4.  Immunization today--a review.

Authors:  M I Marks; M Brazeau; R M Shapera
Journal:  Can Med Assoc J       Date:  1973-06-02       Impact factor: 8.262

5.  A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature.

Authors:  W Halperin; W I Weiss; R Altman; M A Diamond; K J Black; A W Iaci; H C Black; M Goldfield
Journal:  Am J Public Health       Date:  1979-12       Impact factor: 9.308

Review 6.  Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system.

Authors:  Giancarlo Icardi; Andrea Orsi; Antonella Ceravolo; Filippo Ansaldi
Journal:  Hum Vaccin Immunother       Date:  2012-01-01       Impact factor: 3.452

Review 7.  Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis.

Authors:  Jenny L Schnyder; Cornelis A De Pijper; Hannah M Garcia Garrido; Joost G Daams; Abraham Goorhuis; Cornelis Stijnis; Frieder Schaumburg; Martin P Grobusch
Journal:  Travel Med Infect Dis       Date:  2020-09-06       Impact factor: 6.211
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.